期刊文献+

白血病细胞核因子-κB活化与化疗药物诱导凋亡的关系 被引量:11

Relation between activation of NF-κB and chemotherapy induced apoptosis of leukemic cells
原文传递
导出
摘要 目的 研究化疗药物诱导P388白血病细胞核因子 κB (NF κB)活化与凋亡的关系 ,以及长春新碱 (VCR)对它们的影响。方法 采用电泳迁移率变动分析 (EMSA)检测细胞NF κB活化水平 ;采用TdT介导的dUTP缺口末端标记技术 (TUNEL)和DNA电泳方法检测细胞凋亡。结果 化疗药物诱导P388白血病细胞NF κB活化与化疗药物诱导细胞凋亡有明显关系 ,0 .1μmol LVCR不仅能显著抑制 10 0 μmol L阿糖胞苷 (Ara C)或 10 0 μmol L鬼臼乙叉甙 (Vp 16 )诱导的P388细胞NF κB活化 (抑制率分别为 5 2 %和 6 3% ) ,而且增强它们诱导P388细胞凋亡的作用 (凋亡增加率分别为 89%和 12 3% )。P388细胞在接触化疗药物前 ,NF κB亦有一定程度的活化。结论 化疗药物诱导P388白血病细胞凋亡的同时 ,可活化NF κB ;VCR可通过抑制NF κB活化 ,增强化疗药物诱导白血病细胞凋亡的作用。 Objective To analyze the relation between activation of NF κB and chemotherapy induced apoptosis of leukemic cells and the effect of vincristine (VCR) on them. Methods Electrophoretic mobility shift assay (EMSA) was used to detect the activation of NF κB and tunel DNA electrophoresis was adopted to observe the apoptosis induced by cytosine arabinoside (Ara C) and etopside (Vp 1 6) in P388 leukemic cells. Results The activation of NF κB induced by Ara C and Vp 16 was obviously correlated to apoptosis in P388 cells. VCR ( 0.1 μmol/L ) could suppress activation of NF κB by 52% and 63% and significantly increase the apoptosis by 89% and 123% as induced by Ara C(100 μmol/L) and Vp 16(100 μmol/L). The activity of NF κB could be found in P388 cells before being exposed to chemotherapeutic agent. Conclusion Chemotherapeutic agents can induce apoptosis and activation of NF κB of P388 cells. The mechanism of VCR potentiating chemotherapeutics induction of leukemia cell apoptosis may be related to its suppression of the NF κB activaty in the P388 cells. [
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2003年第3期216-219,共4页 Chinese Journal of Oncology
基金 国家自然科学基金资助项目 ( 3 9770 3 3 0 )
关键词 白血病 核因子-ΚB 化疗 细胞凋亡 长春新碱 耐药 Leukemic cell P388 Antieoplasm drug Apoptosis NF κB
  • 相关文献

参考文献9

  • 1Feuillard J, Schuhmacher M, Kohanna S, et al. Inducible loss of NF-κB activity is associated with apoptosis and bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood, 2000,95:2068-2075.
  • 2Wang CY, Cusack JC Jr, Liu R, et al. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med,1999,5:412-417.
  • 3El-Sabban ME, Nasr R, Dbaibo G, et al. Arsenic-interferon-α-triggered apoptosis in HTLV-transformed cells is associated with tax down-regulation and reversal of NF-κB activation. Blood, 2000,96:2849-2855.
  • 4史剑慧,许小平,程文英,罗伟华,王健民,丁训杰.白血病细胞p53和bcl-2表达与化疗药物诱导凋亡的关系[J].中华内科杂志,2000,39(3):181-184. 被引量:8
  • 5Gong J,Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptosis cells applicable for gel electrophoresis and flow cytometry. Anal Biochem, 1994,218: 314-319.
  • 6Reuther JY,Reuther GW,Cortez D, et al. A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev, 1998,12:968-981.
  • 7Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 2000,96:2537-2542.
  • 8Estrov Z, Manna SK, Harris D, et al. Phenylarsine oxide blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells. Blood, 1999, 94:2844-2853.
  • 9Cusack JC Jr, Liu R, Houston M, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-κB inhibition. Cancer Res, 2001,61:3535-3540.

二级参考文献2

  • 1Findley H W,Blood,1997年,89卷,2986页
  • 2Uckun F M,Blood,1997年,89卷,3769页

共引文献7

同被引文献123

引证文献11

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部